https://www.onco3r.com/news 2026-04-28T12:25:23.909Z https://www.onco3r.com/news/approval-first-cta-sik-inhibitor-o3r-5671 2025-09-04 https://www.onco3r.com/news/onco3r-phase1-first-cohort-sik3-o3r-5671 2025-10-06 https://www.onco3r.com/news/onco3r-preclinical-portfolio-aacr-2025 2025-10-22 https://www.onco3r.com/news/completion-first-mad-cohort-phase-1-o3r-5671 2025-12-03 https://www.onco3r.com/news/lawrence-blatt-board-chair-appointment 2026-01-08 https://www.onco3r.com/news/o3r-5671-data-presentation-ecco-dosing-final-cohort 2026-01-09 https://www.onco3r.com/news/ecco-poster-presentation-o3r-5671-data 2026-02-20 https://www.onco3r.com/news/coultreon-biopharma-raises-125-million-series-a 2026-04-28